Testosterone Therapy May Ease Depressive Symptoms

Testosterone Therapy May Ease Depressive Symptoms

Meta-analysis suggests that testosterone treatment enhances mood in hypogonadal and eugonadal men.

Salvage Prostatectomy May Benefit Some Prostate Cancer Patients

Salvage Prostatectomy May Benefit Some Prostate Cancer Patients

Study of men who underwent salvage radical prostatectomy for radiorecurrent prostate cancer found a 10-year rate of biochemical progression-free survival of 33%.

Extraprostatic Extension Indicates Aggressive Prostate Cancer

Extraprostatic Extension Indicates Aggressive Prostate Cancer

Many patients with extraprostatic extension on biopsy experience biochemical recurrence after surgery and require early multi-modal therapy.

Androgen Deprivation Linked With Heart Failure

Androgen Deprivation Linked With Heart Failure

In a study, heart failure was nearly twice as likely to develop among ADT recipients compared with non-recipients.

Study: TRT May Improve Mobility, But Not Fall Risk

Study: TRT May Improve Mobility, But Not Fall Risk

In a study, older men with difficulty walking or climbing stairs reported better physical function after testosterone therapy.

Prostate Cancer Linked to Greater Fat, Fatty Acid Intake

Prostate Cancer Linked to Greater Fat, Fatty Acid Intake

As stearic acid and total fatty acid intake increased from one quintile to the next, prostate risk increased by 23% and 21%, respectively.

Testosterone Therapy Not Linked to Higher Cardiovascular Risks

Testosterone Therapy Not Linked to Higher Cardiovascular Risks

In a recent meta-analysis, testosterone therapy was not associated with major or minor adverse cardiovascular events.

TRT May Reduce Mortality Without Improving CV Health in Diabetes

TRT May Reduce Mortality Without Improving CV Health in Diabetes

In a study, reduced mortality was found among TRT users with type 2 diabetes after adjustment for cardiovascular risk factors.

Radiation Ups Survival When PCa Metastatic Burden Is Low

Radiation Ups Survival When PCa Metastatic Burden Is Low

The 3-year survival rate was 81% for patients who underwent EBRT plus standard care vs 73% for those who had standard care alone.

LDR Brachytherapy for PCa Yields Excellent Outcomes

LDR Brachytherapy for PCa Yields Excellent Outcomes

Long-term data show a local disease recurrence rate of 2.1% at 10 years.

Prostate Cancer ADT Ups Osteoporotic Fracture Risk

Prostate Cancer ADT Ups Osteoporotic Fracture Risk

Among prostate cancer patients, androgen deprivation therapy (ADT) recipients are 34% more likely to experience any osteoporotic fracture than those who do not receive ADT.

Genetic Differences in Prostate Cancer Pinpointed in Black Men

Genetic Differences in Prostate Cancer Pinpointed in Black Men

New findings could help explain why men of African ancestry are more likely than white men to die from prostate cancer.

Elevated PSA at Midlife Predicts Aggressive Prostate Cancer in Blacks

Elevated PSA at Midlife Predicts Aggressive Prostate Cancer in Blacks

A midlife PSA value above the 90th percentile was associated with greater risk of total and aggressive prostate cancer in black men.

Dementia Not Linked to ADT for Prostate Cancer

Dementia Not Linked to ADT for Prostate Cancer

In a study, androgen deprivation therapy did not increase risks for vascular or any other form of dementia among men with prostate cancer who underwent definitive radiation therapy.

Bladder Cancer Risk Higher With Radiation Therapy for Prostate Cancer

Bladder Cancer Risk Higher With Radiation Therapy for Prostate Cancer

In a recently published study, external beam radiation therapy for localized prostate cancer was associated with a 35% increased risk of bladder cancer compared with radical prostatectomy.

Men's Health Latest News

Recreational Marijuana Now Legal in Canada

Recreational Marijuana Now Legal in Canada

Canada is first major world economy to legalize recreational marijuana use

Gardasil 9 Approved for Use in Women and Men 27 Through 45 Years Old

Gardasil 9 Approved for Use in Women and Men 27 Through 45 Years Old

The approval of the expanded age range was based on data from a clinical trial which evaluated the efficacy of Gardasil (quadrivalent human papillomavirus recombinant vaccine) in 3253 women 27-45 years of age with a median duration of follow-up of 3.5 years post-dose 3.

Daily Drinking Associated With Increased Mortality Risk

Daily Drinking Associated With Increased Mortality Risk

Minimum risk of low-level drinking frequency for all-cause mortality found to be about 3 times weekly.

New Testosterone Replacement Therapy Approved for At-Home Self-Administration

New Testosterone Replacement Therapy Approved for At-Home Self-Administration

Xyosted carries a Boxed Warning regarding blood pressure increases that may potentially increase the risk for major adverse cardiovascular events.

Persistent Cancer Screening Gaps Revealed in New CDC Report

Persistent Cancer Screening Gaps Revealed in New CDC Report

From 2000 to 2015 screening for breast, cervical, and prostate cancers decreased significantly, whereas screening for colorectal cancer increased significantly.

Alcohol, Tobacco Consumption Tied to Cancer Mortality

Alcohol, Tobacco Consumption Tied to Cancer Mortality

Over 20 years, a 1-L reduction in alcohol intake was linked to 3.9 percent drop in overall cancer mortality.

Overall Cancer Mortality Rates Decreasing for Men and Women

Overall Cancer Mortality Rates Decreasing for Men and Women

Incidence rates decreased among men from 2008 to 2014, remained stable among women.

Trials Supporting FDA Approval of Breakthrough Drugs Examined

Trials Supporting FDA Approval of Breakthrough Drugs Examined

Pivotal trials supporting these approvals often lack randomization, double-blinding, control groups.

AMA Calls for Inclusive Family, Medical Leave Policies

AMA Calls for Inclusive Family, Medical Leave Policies

Association will advocate for policies inclusive of LGBTQ workers.

Testosterone Prescribing Declining in the US

Testosterone Prescribing Declining in the US

From 2013 to 2016, the relative decrease in testosterone prescriptions was 48% among established testosterone users and 62% among new users.

Men's Health Update Recreational Marijuana Now Legal in Canada

Recreational Marijuana Now Legal in Canada

Canada is first major world economy to legalize recreational marijuana use

Men's Health Update Gardasil 9 Approved for Use in Women and Men 27 Through 45 Years Old

Gardasil 9 Approved for Use in Women and Men 27 Through 45 Years Old

The approval of the expanded age range was based on data from a clinical trial which evaluated the efficacy of Gardasil (quadrivalent human papillomavirus recombinant vaccine) in 3253 women 27-45 years of age with a median duration of follow-up of 3.5 years post-dose 3.

Men's Health Update Daily Drinking Associated With Increased Mortality Risk

Daily Drinking Associated With Increased Mortality Risk

Minimum risk of low-level drinking frequency for all-cause mortality found to be about 3 times weekly.

Men's Health Update New Testosterone Replacement Therapy Approved for At-Home Self-Administration

New Testosterone Replacement Therapy Approved for At-Home Self-Administration

Xyosted carries a Boxed Warning regarding blood pressure increases that may potentially increase the risk for major adverse cardiovascular events.

Men's Health Update Persistent Cancer Screening Gaps Revealed in New CDC Report

Persistent Cancer Screening Gaps Revealed in New CDC Report

From 2000 to 2015 screening for breast, cervical, and prostate cancers decreased significantly, whereas screening for colorectal cancer increased significantly.

Men's Health Update Alcohol, Tobacco Consumption Tied to Cancer Mortality

Alcohol, Tobacco Consumption Tied to Cancer Mortality

Over 20 years, a 1-L reduction in alcohol intake was linked to 3.9 percent drop in overall cancer mortality.

Men's Health Update Overall Cancer Mortality Rates Decreasing for Men and Women

Overall Cancer Mortality Rates Decreasing for Men and Women

Incidence rates decreased among men from 2008 to 2014, remained stable among women.

Men's Health Update Trials Supporting FDA Approval of Breakthrough Drugs Examined

Trials Supporting FDA Approval of Breakthrough Drugs Examined

Pivotal trials supporting these approvals often lack randomization, double-blinding, control groups.

Men's Health Update AMA Calls for Inclusive Family, Medical Leave Policies

AMA Calls for Inclusive Family, Medical Leave Policies

Association will advocate for policies inclusive of LGBTQ workers.

Men's Health Update Testosterone Prescribing Declining in the US

Testosterone Prescribing Declining in the US

From 2013 to 2016, the relative decrease in testosterone prescriptions was 48% among established testosterone users and 62% among new users.

Sign Up for Free e-newsletters